ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ENvue Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.65M. For fiscal 2025 it was -$9.37M. The highest annual figure on record is -$900.00K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.37M | – |
| FY2024 | Dec 31, 2024 | -$2.52M | – |
| FY2023 | Dec 31, 2023 | -$3.60M | – |
| FY2022 | Dec 31, 2022 | -$7.04M | – |
| FY2021 | Dec 31, 2021 | -$4.37M | – |
| FY2020 | Dec 31, 2020 | -$3.39M | – |
| FY2019 | Dec 31, 2019 | -$3.87M | – |
| FY2018 | Dec 31, 2018 | -$3.55M | – |
| FY2017 | Dec 31, 2017 | -$2.18M | – |
| FY2016 | Dec 31, 2016 | -$1.53M | – |
| FY2015 | Dec 31, 2015 | -$1.48M | – |
| FY2014 | Dec 31, 2014 | -$900.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.69M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.68M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.34M | – |
| Q4 FY2024 | Dec 31, 2024 | -$548.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$836.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$553.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$579.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$491.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$682.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.23M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.96M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.00M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$863.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$634.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.92M | – |
| Q1 FY2021 | Mar 31, 2021 | -$954.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.32M | – |
| Q3 FY2020 | Sep 30, 2020 | -$695.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$483.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$895.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$792.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$937.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$881.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$797.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.01M | – |
| Q1 FY2018 | Mar 31, 2018 | -$867.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$780.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$483.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$514.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$405.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$478.00K | – |
See a number that looks wrong?